JD Health International Inc. (HKG:6618)
Hong Kong · Delayed Price · Currency is HKD | Market Cap | 153.09B +23.8% |
| Revenue (ttm) | 81.73B +26.3% |
| Net Income | 5.98B +29.2% |
| EPS | 1.87 +27.3% |
| Shares Out | 3.21B |
| PE Ratio | 25.50 |
| Forward PE | 20.43 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,421,717 |
| Average Volume | 9,580,497 |
| Open | 48.80 |
| Previous Close | 49.64 |
| Day's Range | 47.40 - 49.84 |
| 52-Week Range | 27.15 - 71.70 |
| Beta | 1.16 |
| RSI | 36.85 |
| Earnings Date | Mar 5, 2026 |
About JD Health International
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People’s Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical in... [Read more]
Financial Performance
In 2025, JD Health International's revenue was 73.44 billion, an increase of 26.28% compared to the previous year's 58.16 billion. Earnings were 5.38 billion, an increase of 29.16%.
Financial numbers in CNY Financial StatementsNews
‘The China equity trade is back' and here are the stocks to pick, says SocGen
Early futures action suggest the S&P 500 SPX will open a fraction shy of the fresh record close hit this week.